More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A Fermi Inc. Filed by: Pencross Energy, LLC
-
Form SCHEDULE 13G ROPER TECHNOLOGIES INC Filed by: WINDACRE PARTNERSHIP LLC
-
Form 13F-HR Whetstone Capital Adviso For: Mar 31
-
Form 13F-NT Deerfield UGP, LLC For: Mar 31
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Form PRE 14A Bowen Acquisition Corp For: May 15
-
Form 8-K ARTELO BIOSCIENCES, INC. For: May 11
-
Form 13F-HR Mountain Lake Investment For: Mar 31
-
Form 13F-HR CAT ROCK CAPITAL MANAGEM For: Mar 31
-
Form NT 10-Q NightFood Holdings, Inc. For: Mar 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form NT 10-Q APPYEA, INC For: Mar 31
-
Form 13F-HR Alibaba Group Holding For: Mar 31
-
Form 4 Privacore VPC Asset Back For: May 13 Filed by: CCP 575 Investment Accelerator, LLC
-
Form 8-K IDEXX LABORATORIES INC For: May 12
-
Form SCHEDULE 13G/A BeyondSpring Inc. Filed by: Huang Lan
-
Form SCHEDULE 13G/A ABRDN AUSTRALIA EQUITY Filed by: 1607 Capital Partners, LLC
-
Form 8-K Skye Bioscience, Inc. For: May 13
-
Form 13F-HR Occam Crest Management For: Mar 31
-
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-HR Triveni Capital Investme For: Mar 31
-
Form SCHEDULE 13G Generate Biomedicines, Filed by: Flagship Pioneering, LLC
-
Form 13F-HR Knoll Capital Management For: Mar 31
-
Form SCHEDULE 13G/A Adagio Medical Holdings, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G Once Upon a Farm, PBC Filed by: CAVU Venture Partners II, LP
-
Form 13F-HR Harvey Partners, LLC For: Mar 31
-
Form 13F-HR GREAT POINT PARTNERS For: Mar 31
-
Form 4 PAYCHEX INC For: May 13 Filed by: Roaldsen Elizabeth
-
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-HR WEDGEWOOD PARTNERS INC For: Mar 31
-
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-HR Appaloosa LP For: Mar 31
-
Form SCHEDULE 13G/A enVVeno Medical Corp Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Netskope Inc Filed by: ICONIQ STRATEGIC PARTNERS II, L.P.
-
Form SCHEDULE 13G/A Aldeyra Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A RHYTHM PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A BIODESIX INC Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-HR Select Equity Group, For: Mar 31
-
Form 13F-HR Fort Vancouver Investmen For: Mar 31
-
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-HR SELDON CAPITAL LP For: Mar 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 13F-HR KKM Financial LLC For: Mar 31
-
Form 13F-NT ASOF Investment Manageme For: Mar 31

